FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients

The FDA approved once-daily centanafadine (Simtriyo), the first norepinephrine, dopamine, and serotonin reuptake inhibitor for ADHD in adults and children aged 6 years and older weighing at least 20 kg.